|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 5 of 5
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Hagio, Kanako; Hatanaka, Kanako C.; Amano, Toraji; Matsuno, Yoshihiro; Hatanaka, Yutaka; Yamashita, Hiroko | Genetic heterogeneity during breast cancer progression in young patients | - | Breast | - | Dec-2021 |
| article | Hagio, Kanako; Amano, Toraji; Hayashi, Hideyuki; Takeshita, Takashi; Oshino, Tomohiro; Kikuchi, Junko; Ohhara, Yoshihito; Yabe, Ichiro; Kinoshita, Ichiro; Nishihara, Hiroshi; Yamashita, Hiroko | Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer | - | Scientific reports | - | 14-Apr-2021 |
| article | Kubo, Kimitoshi; Kawakami, Hiroshi; Kuwatani, Masaki; Nishida, Mutsumi; Kawakubo, Kazumichi; Kawahata, Shuhei; Taya, Yoko; Kubota, Yoshimasa; Amano, Toraji; Shirato, Hiroki; Sakamoto, Naoya | Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice : a prospective cohort studya prospective cohort study | - | BMC gastroenterology | - | 8-Jul-2016 |
| article (author version) | Takashina, Taichi; Asahina, Hajime; Oizumi, Satoshi; Yamada, Noriyuki; Harada, Masao; Takamura, Kei; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Ogi, Takahiro; Morikawa, Naoto; Kinoshita, Ichiro; Honda, Ryoichi; Nakano, Kosuke; Kanazawa, Kenya; Amano, Toraji; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu | A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101) | - | International journal of clinical oncology | - | Dec-2018 |
| article (author version) | Ikezawa, Yasuyuki; Asahina, Hajime; Oizumi, Satoshi; Watanabe, Masahiro; Takamura, Kei; Kawai, Yasutaka; Yamada, Noriyuki; Harada, Toshiyuki; Kinoshita, Ichiro; Fujita, Yuka; Miyauchi, Eisaku; Ogi, Takahiro; Amano, Toraji; Furuta, Megumi; Sakakibara-Konishi, Jun; Nishihara, Hiroshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu | A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002) | A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002) | Cancer chemotherapy and pharmacology | - | Nov-2017 |
Showing results 1 to 5 of 5
|
